SJOGRENS SYNDROME
Clinical trials for SJOGRENS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJOGRENS SYNDROME trials appear
Sign up with your email to follow new studies for SJOGRENS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for Sjogren's sufferers in major trial
Disease control OngoingThis study tests an experimental drug called nipocalimab in 655 adults with moderate to severe Sjogren's disease, an autoimmune condition causing dry eyes and mouth. The goal is to see if the drug reduces disease activity over 48 weeks compared to a placebo. Participants must hav…
Matched conditions: SJOGRENS SYNDROME
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 10:39 UTC
-
New drug shows promise for Long-Term Sjögren's control
Disease control OngoingThis study looks at the long-term safety of a drug called ianalumab for people with Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. About 612 participants who completed a previous year-long study will receive ianalumab for up to 3 more years. The goal is…
Matched conditions: SJOGRENS SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:53 UTC